Literature DB >> 29380165

Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?

Rubén Queiro1, Juan D Cañete2.   

Abstract

Cardiovascular risk factors (CVRFs) have been related to poorer responses to systemic therapy in psoriatic arthritis (PsA). We aimed to evaluate the potential association between CVRFs and the achievement of therapeutic goals in PsA patients receiving systemic therapy. A cross-sectional study was carried out at 25 rheumatology outpatient clinics in Spain. PsA patients with established disease who were treated with conventional and biologic systemic therapies were included. The treatment goals measured were minimal disease activity (MDA) and very low disease activity (VLDA) responses. The relationship between MDA/VLDA and CVRFs was evaluated by uni- and multivariate models. Of a total of 227 patients, 133 (58.6%) and 26 (11.5%) patients were in MDA and VLDA, respectively. Tobacco use (crude OR 0.54), sedentary lifestyle (crude OR 1.95), hyperuricemia (crude OR 2.01) and obesity (crude OR 1.54) were related to the likelihood of MDA in the univariate model (p < 0.25), while in multivariate analysis, a sedentary lifestyle (OR 3.13, 95%CI 1.50-6.53; p = 0.002) increased the odds of having reached MDA. Obesity (crude OR 2.2) and dyslipidaemia (crude OR 1.80) were associated with VLDA in univariate analysis, whereas dyslipidaemia (OR 5.3, 95%CI 1.7-16.6; p = 0.004) increased the odds of VLDA in the multivariate model. We found no association between the number of CVRFs and the MDA/VLDA responses. In this cross-sectional, multicentre study, we could not find any relationship between CVRFs and lower odds of achieving stringent therapeutic goals in PsA. In any case, patients with psoriatic disease should be encouraged to maintain healthy lifestyle habits.

Entities:  

Keywords:  Cardiovascular risk factors; Psoriasis; Psoriatic arthritis (PsA)

Mesh:

Substances:

Year:  2018        PMID: 29380165     DOI: 10.1007/s10067-018-4004-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  5 in total

1.  Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study.

Authors:  Rubén Queiro; Estefanía Pardo; Lilyan Charca; Sara Alonso; Luis Arboleya; Mercedes Alperi
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

Review 2.  Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence.

Authors:  Laura C Coates; Maarten de Wit; Amy Buchanan-Hughes; Maartje Smulders; Anna Sheahan; Alexis R Ogdie
Journal:  Rheumatol Ther       Date:  2022-04-12

Review 3.  The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review.

Authors:  Juan D Cañete; Jose Antonio Pinto Tasende; Francisco José Rebollo Laserna; Susana Gómez Castro; Rubén Queiro
Journal:  Rheumatol Ther       Date:  2020-04-08

4.  Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study.

Authors:  Ruben Queiro; Juan D Cañete; María Montoro; Susana Gómez; Ana Cábez
Journal:  Arthritis Res Ther       Date:  2020-04-15       Impact factor: 5.156

5.  Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study.

Authors:  Ennio Lubrano; Silvia Scriffignano; Ana Belen Azuaga; Julio Ramirez; Juan D Cañete; Fabio Massimo Perrotta
Journal:  Rheumatol Ther       Date:  2020-08-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.